Table 4 Correlation of the serum NO level with metabolic syndrome components in the case and control groups.
Parameter | People | r | p-value |
|---|---|---|---|
BMI | Case | −0.207 | 0.149⁑ |
Control | −0.1 | 0.49⁑ | |
WC (cm) | Case | 0.13 | 0.34* |
Control | 0.14 | 0.32* | |
HDL (mg/dL) | Case | 0.21 | 0.12* |
Control | −0.12 | 0.37 * | |
FBS (mg/dL) | Case | −0.20 | 0.15* |
Control | −0.13 | 0.34* | |
TG (mg/dL) | Case | −0.11 | 0.41⁑ |
Control | −0.03 | 0.83⁑ | |
SBP (mm Hg) | Case | −0.3 | 0.31* |
Control | −0.12 | 0.38* | |
DBP (mm Hg) | Case | −0.24 | 0.09* |
Control | −0.01 | 0.91* | |
Metabolic syndrome | Case | −0.19 | 0.16* |
Control | −0.09 | 0.52* |
